KiSS-1 Expression in Human Breast Cancer

Overview

Journal Clin Exp Metastasis

Specialty Oncology

Date 2005 Dec 2

PMID 16320113

Citations 42

Authors

Tracey A Martin

Gareth Watkins

Wen G Jiang

Affiliations

Soon will be listed here.

Abstract

The KiSS-1 gene encodes a 145 amino acid residue peptide that is further processed to a final peptide, metastin, a ligand to a G-coupled orphan receptor (OT7T175/AXOR12). KiSS-1 has been identified as a putative human metastasis suppressor gene in melanomas and in breast cancer cell lines. This study aimed to determine the expression and distribution of KiSS-1 and its receptor in human breast cancer tissues and to identify a possible link between expression levels and patient prognosis. Frozen sections from breast cancer primary tumours (matched tumour 124 and background 33) were immuno-stained with KiSS-1 antibody. RNA was reverse transcribed and analyzed by Q-PCR (standardized using beta-actin, and normalized with cytokeratin-19 levels). Levels of expression of KiSS-1 were higher in tumour compared to background tissues (3,124+/-1,262 vs 2,397+/-1,181) and significantly increased in node positive tumours compared to node negative (3,637+/-1,719 vs 2,653+/-1,994, P = 0.02). KiSS-1 expression was also increased with increasing grade and TNM status. There were no such trends with the KiSS-1 receptor. Expression of KiSS-1 was higher in patients who had died from breast cancer than those who had remained healthy (4,631+/-3,024 vs 2,280+/-1,403) whereas expression of the receptor was reduced (480+/-162 vs 195+/-134). Immunohistochemical staining showed increased expression of KiSS-1 in tumour sections. Insertion of the KiSS-1 gene into the human breast cancer cell line MDA-MB-231, resulted in cells that were significantly more motile and invasive in behaviour, with reduced adhesion to matrix, using respective assays. In conclusion, KiSS-1 expression is increased in human breast cancer, particularly in patients with aggressive tumours and with mortality. Over-expression of KiSS-1 in breast cancer cells result in more aggressive phenotype. Together, it suggests that KiSS-1 plays a role beyond the initial metastasis repressor in this cancer type.

Citing Articles

Comprehensive Analysis of Kisspeptin Signaling: Effects on Cellular Dynamics in Cervical Cancer.

Rodriguez-Sarmiento D, Rondon-Villarreal P, Scarpelli-Pereira P, Bouvier M Biomolecules. 2024; 14(8).

PMID: 39199311 PMC: 11352469. DOI: 10.3390/biom14080923.

Inverse Correlation of KISS1 and KISS1R Expression in Triple-negative Breast Carcinomas from African American Women.

Qasim M, Ricks-Santi L, Naab T, Rajack F, Beyene D, Abbas M Cancer Genomics Proteomics. 2022; 19(6):673-682.

PMID: 36316037 PMC: 9620443. DOI: 10.21873/cgp.20350.

Lack of Oestrogen Receptor Expression in Breast Cancer Cells Does Not Correlate with Kisspeptin Signalling and Migration.

Azubuike U, Newton C, van den Bout I Int J Mol Sci. 2022; 23(15).

PMID: 35955878 PMC: 9368979. DOI: 10.3390/ijms23158744.

Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer.

Yellapu N, Ly T, Sardiu M, Pei D, Welch D, Thompson J BMC Cancer. 2022; 22(1):627.

PMID: 35672711 PMC: 9173973. DOI: 10.1186/s12885-022-09690-2.

Evaluation of KISS1 Receptor Gene Expression in Egyptian Female Patients with Breast Cancer.

Gomaa S, Zaki M, Sultan M, Dwedar F, Elzain Zidan E Asian Pac J Cancer Prev. 2022; 23(3):961-969.

PMID: 35345369 PMC: 9360929. DOI: 10.31557/APJCP.2022.23.3.961.

References

Kominsky S, Argani P, Korz D, Evron E, Raman V, Garrett E . Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene. 2003; 22(13):2021-33. DOI: 10.1038/sj.onc.1206199. View

Martin T, Watkins G, Mansel R, Jiang W . Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer. 2004; 40(18):2717-25. DOI: 10.1016/j.ejca.2004.08.008. View

Dhar D, Naora H, Kubota H, Maruyama R, Yoshimura H, Tonomoto Y . Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma. Int J Cancer. 2004; 111(6):868-72. DOI: 10.1002/ijc.20357. View

Jiang W, Watkins G, Lane J, Cunnick G, Douglas-Jones A, Mokbel K . Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin Cancer Res. 2003; 9(17):6432-40. View

Sanchez-Carbayo M, Capodieci P, Cordon-Cardo C . Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome. Am J Pathol. 2003; 162(2):609-17. PMC: 1851149. DOI: 10.1016/S0002-9440(10)63854-0. View

Ringel M, Hardy E, Bernet V, Burch H, Schuppert F, Burman K . Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. J Clin Endocrinol Metab. 2002; 87(5):2399. DOI: 10.1210/jcem.87.5.8626. View

Hori A, Honda S, Asada M, Ohtaki T, Oda K, Watanabe T . Metastin suppresses the motility and growth of CHO cells transfected with its receptor. Biochem Biophys Res Commun. 2001; 286(5):958-63. DOI: 10.1006/bbrc.2001.5470. View

Shirasaki F, Takata M, Hatta N, Takehara K . Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. Cancer Res. 2001; 61(20):7422-5. View

Horikoshi Y, Matsumoto H, Takatsu Y, Ohtaki T, Kitada C, Usuki S . Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab. 2003; 88(2):914-9. DOI: 10.1210/jc.2002-021235. View

10.

Welch D, Hunter K . A new member of the growing family of metastasis suppressors identified in prostate cancer. J Natl Cancer Inst. 2003; 95(12):839-41. DOI: 10.1093/jnci/95.12.839. View

11.

Ellison G, Klinowska T, Westwood R, Docter E, French T, Fox J . Further evidence to support the melanocytic origin of MDA-MB-435. Mol Pathol. 2002; 55(5):294-9. PMC: 1187258. DOI: 10.1136/mp.55.5.294. View

12.

Ikeguchi M, Yamaguchi K, Kaibara N . Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma. Clin Cancer Res. 2004; 10(4):1379-83. DOI: 10.1158/1078-0432.ccr-1519-02. View

13.

Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden J, Le Poul E . The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem. 2001; 276(37):34631-6. DOI: 10.1074/jbc.M104847200. View

14.

Goldberg S, Miele M, Hatta N, Takata M, Paquette-Straub C, Freedman L . Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res. 2003; 63(2):432-40. View

15.

Hiscox S, Jiang W . Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells. Biochem Biophys Res Commun. 1999; 261(2):406-11. DOI: 10.1006/bbrc.1999.1002. View

16.

Lee J, Miele M, Hicks D, Phillips K, Trent J, Weissman B . KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst. 1996; 88(23):1731-7. DOI: 10.1093/jnci/88.23.1731. View

17.

Lee J, Welch D . Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res. 1997; 57(12):2384-7. View

18.

Funes S, Hedrick J, Vassileva G, Markowitz L, Abbondanzo S, Golovko A . The KiSS-1 receptor GPR54 is essential for the development of the murine reproductive system. Biochem Biophys Res Commun. 2003; 312(4):1357-63. DOI: 10.1016/j.bbrc.2003.11.066. View

19.

Ross D, Scherf U, Eisen M, Perou C, Rees C, Spellman P . Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet. 2000; 24(3):227-35. DOI: 10.1038/73432. View

20.

Davies G, Jiang W, Mason M . Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells. J Urol. 2000; 163(3):985-92. View